RNAi Technology and Investigation on Possible Vaccines to Combat SARS-CoV-2 Infection

被引:3
|
作者
Talukder, Pratik [1 ]
Chanda, Sounak [1 ]
机构
[1] Univ Engn & Management, Dept Biotechnol, St 03,Act Area 3,B-5, Kolkata 700156, W Bengal, India
关键词
COVID-19; Vaccine; ACE2; receptors; Antibody; Antigen; siRNA; Gene silencing; RESPIRATORY SYNDROME CORONAVIRUS; SARS-COV; PROTEIN; IDENTIFICATION; NANOCARRIERS; MODEL; MICE;
D O I
10.1007/s12010-021-03548-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Coronavirus disease of 2019 (COVID-19) pandemic, taking place globally, occurs as a result of the SARS-CoV-2 viral infection which has caused death of innumerable numbers of people and is responsible for a massive drop in the global economy. Millions of people are infected, and the death rate is also quite high in different countries. So, there is an urgent requirement of the invention of some effective and efficient drugs that can be effective against this deadly viral infection. The invention of new drugs and vaccine has become a matter of utmost importance to stop the mayhem of coronavirus pandemic. In the middle of such a deadly pandemic, the necessity of development of a vaccine is of high importance in this context. Among all the popular methods of vaccine development, the mRNA vaccines turned out to be the one of the most versatile vaccine with quick responses. However, in this review, we have explained all the possible types of vaccines available including DNA vaccines, RNA vaccines, and live and attenuated vaccines. Their effectiveness, importance, and application of the vaccines against the SARS-CoV-2 virus have been discussed. Research is also being conducted in the field of gene silencing, and one of the best possible ways to combat the virus at the molecular level is by applying RNAi technology. The modified siRNA molecules can be used to silence the gene expression of the virus. A summarization of the virus's behavior, characteristics, and the methods by which RNAi technology can be administered to control the virus is depicted in this study.
引用
收藏
页码:1744 / 1756
页数:13
相关论文
共 50 条
  • [21] An Effective Platform for SARS-CoV-2 Prevention by Combining Neutralization and RNAi Technology
    Zhou, Jun-Xiang
    Yin, Xue
    Liang, Hao-Jun
    CHINESE JOURNAL OF POLYMER SCIENCE, 2023, 41 (03) : 327 - 333
  • [22] Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
    Ahluwalia, Pankaj
    Vaibhav, Kumar
    Ahluwalia, Meenakshi
    Mondal, Ashis K.
    Sahajpal, Nikhil
    Rojiani, Amyn M.
    Kolhe, Ravindra
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [23] SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines
    Li, Xi
    Mi, Ze
    Liu, Zhenguo
    Rong, Pengfei
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [24] Lactoferrin as a Possible Preventive and Therapeutic Agent Against SARS-CoV-2 Infection
    Kobayashi-Sakamoto, Michiyo
    Maeda, Toyonobu
    Yusa, Junko
    Tani, Hideki
    Kato, Yasumasa
    Hirose, Kimiharu
    JOURNAL OF DISASTER RESEARCH, 2023, 18 (01) : 27 - 33
  • [25] Advances in the design and development of SARS-CoV-2 vaccines
    Peng, Xue-Liang
    Cheng, Ji-Si-Yu
    Gong, Hai-Lun
    Yuan, Meng-Di
    Zhao, Xiao-Hong
    Li, Zibiao
    Wei, Dai-Xu
    MILITARY MEDICAL RESEARCH, 2021, 8 (01)
  • [26] The discovery and development of mRNA vaccines for the prevention of SARS-CoV-2 infection
    Xue, Vivian Weiwen
    Wong, Sze Chuen Cesar
    Li, Bo
    Cho, William Chi Shing
    EXPERT OPINION ON DRUG DISCOVERY, 2023, 18 (07) : 769 - 780
  • [27] SARS-CoV-2 Variants, Vaccines, and Host Immunity
    Mistry, Priyal
    Barmania, Fatima
    Mellet, Juanita
    Peta, Kimberly
    Strydom, Adele
    Viljoen, Ignatius M.
    James, William
    Gordon, Siamon
    Pepper, Michael S.
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [28] Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains
    Padron-Regalado, Eriko
    INFECTIOUS DISEASES AND THERAPY, 2020, 9 (02) : 255 - 274
  • [29] SARS-CoV-2: Unique Challenges of the Virus and Vaccines
    Mahmoodpoor, Ata
    Sanaie, Sarvin
    Samadi, Parisa
    Yousefi, Mehdi
    Nader, Nader D.
    IMMUNOLOGICAL INVESTIGATIONS, 2021, 50 (07) : 802 - 809
  • [30] Diagnostic Testing for SARS-CoV-2 Infection
    Thomas E.
    Delabat S.
    Andrews D.M.
    Current Hepatology Reports, 2021, 20 (4) : 166 - 174